Viking Therapeutics Inc (VKTX)
65.07
+0.14
(+0.22%)
USD |
NASDAQ |
Apr 24, 16:00
64.32
-0.75
(-1.15%)
After-Hours: 04:22
Viking Therapeutics Cash from Operations (TTM): -73.38M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -73.38M |
September 30, 2023 | -66.66M |
June 30, 2023 | -60.50M |
March 31, 2023 | -62.51M |
December 31, 2022 | -48.40M |
September 30, 2022 | -49.82M |
June 30, 2022 | -47.25M |
March 31, 2022 | -47.24M |
December 31, 2021 | -47.59M |
September 30, 2021 | -40.72M |
June 30, 2021 | -35.12M |
March 31, 2021 | -28.35M |
December 31, 2020 | -21.78M |
September 30, 2020 | -28.03M |
June 30, 2020 | -26.11M |
March 31, 2020 | -25.90M |
December 31, 2019 | -24.75M |
September 30, 2019 | -15.69M |
June 30, 2019 | -17.79M |
March 31, 2019 | -16.60M |
Date | Value |
---|---|
December 31, 2018 | -18.76M |
September 30, 2018 | -20.02M |
June 30, 2018 | -17.85M |
March 31, 2018 | -16.78M |
December 31, 2017 | -14.76M |
September 30, 2017 | -13.28M |
June 30, 2017 | -12.60M |
March 31, 2017 | -11.63M |
December 31, 2016 | -11.07M |
September 30, 2016 | -11.91M |
June 30, 2016 | -12.65M |
March 31, 2016 | -11.05M |
December 31, 2015 | -8.732M |
September 30, 2015 | -5.873M |
June 30, 2015 | -3.082M |
March 31, 2015 | -1.902M |
December 31, 2014 | -1.591M |
September 30, 2014 | -1.160M |
June 30, 2014 | -0.5506M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-73.38M
Minimum
Dec 2023
-15.69M
Maximum
Sep 2019
-40.40M
Average
-40.72M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Eli Lilly and Co | 4.240B |
Pfizer Inc | 8.70B |
Madrigal Pharmaceuticals Inc | -324.23M |
Akero Therapeutics Inc | -145.37M |
Terns Pharmaceuticals Inc | -67.39M |